These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatic dysfunction and fever associated with hypernephroma. Tartaglia AP; Wolfe S; Propp S N Y State J Med; 1970 Sep; 70(17):2231-4. PubMed ID: 5273004 [No Abstract] [Full Text] [Related]
3. [Epilepsy and "reversible hepatic damage" associated with hypernephroma]. Fossaluzza V; Monte P; Comino P Minerva Urol; 1979; 31(4):229-32. PubMed ID: 542196 [No Abstract] [Full Text] [Related]
6. [Liver dysfunction syndrome during kidney cancer]. Niquet G; Lhermine C; Dehaene P; Defrance G; Dupuich Y Lille Med; 1978 Dec; 23(10):709-13. PubMed ID: 748706 [No Abstract] [Full Text] [Related]
7. [Contribution to the aetiology of "reversible hepatic dysfunction" (Stauffer's syndrome) associated with renal tumours]. Girmann G; Gratzl M; Pees H; Seebach HB; Scheurlen PG Dtsch Med Wochenschr; 1975 Mar; 100(10):480-4. PubMed ID: 1112200 [TBL] [Abstract][Full Text] [Related]
8. [Reversible disorders of hepatic function in cancer of the kidney]. Cachin M; Lévy C; Monnier JP Sem Hop; 1970 Mar; 46(12):814-6. PubMed ID: 4317081 [No Abstract] [Full Text] [Related]
9. ["Unclear" disorders of liver function (Stauffer syndrome) in hypernephroid carcinoma]. Saalfeld J; Battke H Z Arztl Fortbild (Jena); 1980 Feb; 74(3):113-4. PubMed ID: 6158183 [No Abstract] [Full Text] [Related]
10. [Hepatosplenomegaly in the course of hypernephroma]. Micić R; Arsenijević M; Krstić N; Ceramilac A Srp Arh Celok Lek; 1967 Sep; 95(9):827-34. PubMed ID: 5628517 [No Abstract] [Full Text] [Related]
11. [Grawitz tumor and the liver]. Petera V; Důra J; Motán J; Krivánek V Cesk Gastroenterol Vyz; 1971 Mar; 25(2):52-6. PubMed ID: 5574748 [No Abstract] [Full Text] [Related]
12. Cystic liver disease with associated hypernephroma. Case report. Petroski D; Stafford C; Coodley EL Am J Gastroenterol; 1973 Mar; 59(3):255-61. PubMed ID: 4267140 [No Abstract] [Full Text] [Related]
13. [Regression of amyloidosis. Disappearance of massive hepatic amyloidosis after nephrectomy for cancer]. Paraf A; Coste T; Rautureau J; Texier J Presse Med (1893); 1970 Mar; 78(12):547-8. PubMed ID: 5439190 [No Abstract] [Full Text] [Related]
14. Hepatic dysfunction associated with hypernephroma. Robinson TJ Ir Med J; 1980 Jul; 73(7):277-8. PubMed ID: 7440122 [No Abstract] [Full Text] [Related]
15. [Organ-sparing operation in echinococcosis and cancer of the kidney]. Imamverdiev SB; Kolesnikova EV Vestn Khir Im I I Grek; 1988 Jun; 140(6):50-2. PubMed ID: 3222865 [No Abstract] [Full Text] [Related]
16. [Nonmetastatic hepatomegaly associated with hypernephroma]. Desché-Labarthe S; Schaeffer A; Boccon-Gibod L; Aboulker P; Laroche C Ann Med Interne (Paris); 1971 Feb; 122(2):281-6. PubMed ID: 5579430 [No Abstract] [Full Text] [Related]
17. Reversible non-metastatic liver-cell dysfunction and thrombocytosis from a hypernephroma. Mohamed SD Lancet; 1965 Sep; 2(7413):621-3. PubMed ID: 4157563 [No Abstract] [Full Text] [Related]
19. [Possibility of the regression of amyloidosis: disappearance of massive liver amyloidosis after nephrectomy for cancer]. Paraf A; Rautureau J; Coste T; Texier J Ann Med Interne (Paris); 1969 May; 120(5):351-62. PubMed ID: 5405206 [No Abstract] [Full Text] [Related]
20. [Resection of congenital solitary kidney with adenocarcinoma]. Grin'ko AD Urol Nefrol (Mosk); 1975; (5):49-50. PubMed ID: 1231115 [No Abstract] [Full Text] [Related] [Next] [New Search]